This workshop focuses on integrating the EU AI Act into MDR/IVDR by unifying QMS, documentation, and risk management, while also demonstrating how AI tools can handle regulatory data and automate compliance
Many companies struggle to align the EU AI Act with Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), as each framework focuses on different aspects AI Act on data governance and transparency, and MDR/IVDR on safety and performance.
The most effective solution is to integrate AI Act requirements into existing documentation and quality systems to avoid duplication.
This workshop demonstrates how to do this by embedding AI obligations into QMS, managing both safety and fundamental-rights risks, and creating unified technical documentation, while also guiding organizations to adapt roles and governance for successful AI integration.
Between the plenary teaching parts of the workshop, participants will be given a case study to work on, for medical devices and AI. The use of AI tools for this assignment is encouraged.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.







CEO, AKRA TEAM
Dr. Bassil Akra is a distinguished leader in medical device and in-vitro diagnostic device regulation, with extensive expertise spanning R&D, manufacturing, testing, conformity assessment, and standards development. As Chief Executive Officer of AKRA TEAM since July 2021, he supports the various stakeholders in developing and executing compliant regulatory, clinical, and quality strategies in the EU, effectively bridging the language between legislators, notified bodies, and industry stakeholders. He also supports the various due diligence activities and court cases which require his independent and impartial subject matter expertise.
A recognized authority in the European medtech regulatory arena, Dr. Akra has been instrumental in shaping the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). His contributions to regulatory frameworks extend to active involvement in developing Medical Device Coordination Group (MDCG) guidance documents and participating in critical regulatory updates that continue to define industry standards and best practices. Dr. Akra contributed to the ongoing revision of the EU MDR and IVDR as an advisor during the survey initiated by the EU Commission and was contracted later when evaluating the impact of the proposed changes on the healthcare system.
Dr. Akra's impressive career includes nearly a decade of work at the largest notified body in the Union Market: TÜV SÜD Product Service, where he progressed from Product Specialist to Vice President, ultimately leading global strategic business development and focus teams across cardiovascular, orthopedic, active implantable, aesthetic, and clinical domains. His instrumental role in building Notified Body capabilities in these critical areas established him as a key architect of success for the organization. Prior to his regulatory career, he served as Head of the Research Group Tissue Engineering in the Department of Cardiac Surgery at Klinikum der Universität München for over eight years. In this role, he worked with key MedTech Industry and healthcare professionals on designing, testing, and developing innovation in the cardiovascular sector.
Currently, Dr. Akra holds multiple leadership positions, including Vice President of TEAM-PRRC, Chair of the Scientific Advisory Board at 3Aware, Co-Founder and Board Member at Raiana, Board Member at MEDDEVO, CEO of B2MAS Holding, Advisory Board Member at Milo Health, and Lecturer at TUM Munich.

Founder and Senior Regulatory Consultant, CREATE
No bio provided
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.